CN Patent

CN107376071B — 用于将化合物递送到使用者的上部嗅觉区的喷嘴

Assigned to Inbell Pharmaceutical Co · Expires 2021-07-09 · 5y expired

What this patent protects

本发明涉及用于将化合物递送到使用者的上部嗅觉区的喷嘴。该喷嘴包括：具有中心轴线的喷嘴主体，容置在所述喷嘴主体内的多个通道，所述通道具有近端和远端，设置在所述通道的所述近端的入口，以及设置在所述通道的所述远端的出口孔，所述出口孔平行于所述喷嘴的所述中心轴线布置。

USPTO Abstract

本发明涉及用于将化合物递送到使用者的上部嗅觉区的喷嘴。该喷嘴包括：具有中心轴线的喷嘴主体，容置在所述喷嘴主体内的多个通道，所述通道具有近端和远端，设置在所述通道的所述近端的入口，以及设置在所述通道的所述远端的出口孔，所述出口孔平行于所述喷嘴的所述中心轴线布置。

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: CN107376071B
Jurisdiction: CN
Classification: —
Expires: 2021-07-09
Drug substance claim: No
Drug product claim: No
Assignee: Inbell Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.